Cappagli B - Search Results

1

Longitudinal evaluation of perimenopausal vertebral bone loss: effects of a low-dose oral contraceptive preparation on bone mineral density and metabolism.

Gambacciani M, Spinetti A, Taponeco F, Cappagli B, Piaggesi L, Fioretti P. Gambacciani M, et al. Among authors: cappagli b. Obstet Gynecol. 1994 Mar;83(3):392-6. Obstet Gynecol. 1994. PMID: 8127531 Clinical Trial.

2

Longitudinal evaluation of perimenopausal bone loss: effects of different low dose oral contraceptive preparations on bone mineral density.

Gambacciani M, Cappagli B, Lazzarini V, Ciaponi M, Fruzzetti F, Genazzani AR. Gambacciani M, et al. Among authors: cappagli b. Maturitas. 2006 May 20;54(2):176-80. doi: 10.1016/j.maturitas.2005.10.007. Epub 2005 Dec 5. Maturitas. 2006. PMID: 16332417 Clinical Trial.

3

Ultrasonographic bone characteristics during normal pregnancy: longitudinal and cross-sectional evaluation.

Gambacciani M, Spinetti A, Gallo R, Cappagli B, Teti GC, Facchini V. Gambacciani M, et al. Among authors: cappagli b. Am J Obstet Gynecol. 1995 Sep;173(3 Pt 1):890-3. doi: 10.1016/0002-9378(95)90361-5. Am J Obstet Gynecol. 1995. PMID: 7573264

4

Hormone replacement therapy in perimenopausal women with a low dose oral contraceptive preparation: effects on bone mineral density and metabolism.

Gambacciani M, Spinetti A, Cappagli B, Taponeco F, Maffei S, Piaggesi L, Fruzzetti F, Fioretti P. Gambacciani M, et al. Among authors: cappagli b. Maturitas. 1994 Aug;19(2):125-31. doi: 10.1016/0378-5122(94)90062-0. Maturitas. 1994. PMID: 7968645 Clinical Trial.

5

Bone loss in perimenopausal women: a longitudinal study.

Gambacciani M, Spinetti A, Taponeco F, Cappagli B, Maffei S, Manetti P, Piaggesi L, Fioretti P. Gambacciani M, et al. Among authors: cappagli b. Maturitas. 1994 Mar;18(3):191-7. doi: 10.1016/0378-5122(94)90125-2. Maturitas. 1994. PMID: 8015502

6

Effects of ipriflavone administration on bone mass and metabolism in ovariectomized women.

Gambacciani M, Spinetti A, Cappagli B, Taponeco F, Felipetto R, Parrini D, Cappelli N, Fioretti P. Gambacciani M, et al. Among authors: cappagli b. J Endocrinol Invest. 1993 May;16(5):333-7. doi: 10.1007/BF03348848. J Endocrinol Invest. 1993. PMID: 8320424 Clinical Trial.

7

Treatment of postmenopausal vertebral osteopenia with monofluorophospate: a long-term calcium-controlled study.

Gambacciani M, Spinetti A, Taponeco F, Piaggesi L, Cappagli B, Ciaponi M, Rovati LC, Genazzani AR. Gambacciani M, et al. Among authors: cappagli b. Osteoporos Int. 1995;5(6):467-71. doi: 10.1007/BF01626610. Osteoporos Int. 1995. PMID: 8695970 Clinical Trial.

8

Ipriflavone prevents the loss of bone mass in pharmacological menopause induced by GnRH-agonists.

Gambacciani M, Cappagli B, Piaggesi L, Ciaponi M, Genazzani AR. Gambacciani M, et al. Among authors: cappagli b. Calcif Tissue Int. 1997;61 Suppl 1:S15-8. doi: 10.1007/s002239900379. Calcif Tissue Int. 1997. PMID: 9263611 Clinical Trial.

9

Effects of combined low dose of the isoflavone derivative ipriflavone and estrogen replacement on bone mineral density and metabolism in postmenopausal women.

Gambacciani M, Ciaponi M, Cappagli B, Piaggesi L, Genazzani AR. Gambacciani M, et al. Among authors: cappagli b. Maturitas. 1997 Sep;28(1):75-81. doi: 10.1016/s0378-5122(97)00059-5. Maturitas. 1997. PMID: 9391998 Clinical Trial.

10

Hormone replacement therapy in perimenopause: effect of a low dose oral contraceptive preparation on bone quantitative ultrasound characteristics.

Gambacciani M, Cappagli B, Ciaponi M, Benussi C, Genazzani AR. Gambacciani M, et al. Among authors: cappagli b. Menopause. 1999 Spring;6(1):43-8. Menopause. 1999. PMID: 10100179 Clinical Trial.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

27 results

Search Page

Filters